The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension
- 15 May 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (10) , 1292-1299
Abstract
This Perspective provides an in depth overview of the many aspects of inflammation which are associated with many forms of severe pulmonary hypertension.Details of the pathobiology of severe pulmonary hypertension are discussed in the context of the multicellular inflammatory vascular infiltrates which represent a lung vessel response to injury and and a localized immune response.The important question whether inflammation is cause or consequence of pulmonary hypertension should not distract from designing and conducting clinical pilot studies which examine the efficacy of existing immune system modulating drugs.Keywords
This publication has 118 references indexed in Scilit:
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Regulatory T Cells and Pulmonary HypertensionTrends in Cardiovascular Medicine, 2011
- Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in miceImmunology & Cell Biology, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertensionRespiratory Medicine, 2010
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- IL-32–dependent effects of IL-1β on endothelial cell functionsProceedings of the National Academy of Sciences, 2009
- Pulmonary arterial remodeling induced by a Th2 immune responseJournal of Experimental Medicine, 2008
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences, 2007
- Alternative activation of macrophagesNature Reviews Immunology, 2003